Development

Greg Paddon-Jones, PhD, is director of Product Development at Antares Health Products.

Articles

The author discusses some new applications of TPGS in the pharmaceutical field that should see this versatile excipient retain its place in the drug formulators toolbox.

Emerging Applications of Vitamin E TPGS in Drug Delivery

Meg Rivers is the former senior editor for 

One company reaches beyond traditionally-conceived male contraceptives with Vasalgel, a reversible hydrogel injectable. 

The Next Generation of Male Contraceptives

Hanna Jankevics Jones, PhD, is a pharmaceutical segment marketing manager at Malvern Panalytical.

Natalia Markova is principal scientist, MicroCal, Malvern Instruments.

Using an orthogonal approach to lipid nanoparticle analysis can increase the odds of project success.

Shining a Light on Lipid Nanoparticle Characterization

Some of the greatest advancements in drug delivery are related to disposable delivery devices, vaccine adjuvants, and wearable pumps, according to Nicholas W. Warne of Pfizer.

The Future of Drug Delivery for Biopharmaceuticals

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Putting the patient at the forefront of drug development is essential, particularly to ensure medication compliance is optimized.

Focusing on the Patient in Drug Development

The inaugural Connect in Pharma event will take place on 14 and 15 September in Geneva, Switzerland.

Connecting the Dots for Pharma

Feliza Mirasol is the science editor for 

Videos

In this episode of Drug Digest, Pharmaceutical Technology editors, Felicity Thomas and Feliza Mirasol, examine the topic of emerging therapies in more detail, covering subjects such as the challenges of scale, the potential benefits of drug delivery innovation, importance of early analytical studies, the evolution of the regulatory landscape, and differences between regional regulatory requirements.

Drug Digest: Emerging Therapies in All Shapes and Sizes

Advances in therapeutic modalities and an increase in molecular complexity have led to the need for an evolution in drug delivery approaches over the years.

An Evolving Approach to Drug Delivery 

Lonza has joined IPAC-RS, providing benefits to Lonza’s inhalation- related businesses due to IPAC-RS’ global voice of the orally inhaled and nasal drug products industry.

Lonza Joins IPAC-RS, an International Consortium Advancing the Regulatory Science of Inhalation Products

Sanofi is collaborating with Blackstone Life Sciences to accelerate the development of a treatment for multiple myeloma.